New Drug Trial Aims to Reduce Ectopic Pregnancy Surgeries

University of Aberdeen researchers test mifepristone to improve non-surgical treatment success rates.

Ectopic pregnancies occur in about one in 80 pregnancies, often requiring emergency surgery.
Current treatment with methotrexate fails in 30% of cases, necessitating surgical intervention.
The trial will test mifepristone, which blocks the hormone progesterone, alongside methotrexate.
Hundreds of women across 40 UK hospitals will participate in the trial starting later this year.
Results from the £1.6 million trial are expected in 2027, potentially marking a significant medical advancement.